INSIGHTS ON DRUG DEVELOPMENT
-
VEGF Signaling Pathway
In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.
-
Non Animal Origin Squalene For High-Risk Applications
Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.
-
Viral Gene Therapy: Reducing Costs To Improve Patient Access
Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.
-
A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics
Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.
-
Solid Formulation: Spray Drying Process7/24/2025
Transform your pharmaceutical development with an innovative spray drying technology that enhances API solubility to improve drug bioavailability and formulation performance.
-
Leveraging Innovative Analytics To Ensure The Thermal Stability Of mAb Drug Products9/23/2024
Uncover how innovative Rapid Screening-Differential Scanning Calorimeter technology is enabling robust analysis and regulatory compliance by ensuring the thermal stability of antibody drug products.
-
Scientific Data Is Not AI‑Ready By Default6/26/2026
Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.
-
Injection Site Reaction Screening Methodology6/6/2025
Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.
-
A Digital Dispenser For Single-Cell And Low-Input Proteomics11/7/2025
Discover a high-precision dispensing system that enables rapid, low-volume sample prep for single-cell proteomics to support flexible workflows, maintain cell integrity, and deliver reliable results.
DRUG DEVELOPMENT SOLUTIONS
-
Explore end-to-end services offered by a trusted CDMO partner with more than 15 years of industry-leading experience in conjugation and purpose-built manufacturing facilities.
-
Tailored support is available for diverse molecules, including small and large molecules, nucleic acid therapies, and novel delivery systems. Services span drug substance to regulatory affairs.
-
Explore the design services offered by the Gibco Media by Design team including cell line development, media and feed panel evaluations, bioproduction analytics and more.
-
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to inadequate insulin production or impaired insulin utilization, commonly known as insulin resistance.
-
STELLARIS 8 FALCON FLIM Microscope
The contrast is clear. Lifetime imaging in an instant.
STELLARIS 8 FALCON (FAst Lifetime CONtrast) is the future of functional imaging. Harness the power of fluorescence lifetime to investigate cellular physiology and explore dynamics in living cells. STELLARIS 8 FALCON is a fully integrated solution for Fluorescence Lifetime Imaging (FLIM) and enables video-rate lifetime imaging acquisition for rapid kinetic studies in live cells.
STELLARIS 8 FALCON adds a new dimension of contrast to your imaging, opening the door to biosensing and tracking of interactions between proteins. FLIM information is now available for all modalities of the STELLARIS 8 system.